SMS Pharmaceuticals consolidated net profit rises 57.45% in the September 2026 quarter

Sales rise 30.38% to Rs 316.09 crore

Net profit of SMS Pharmaceuticals rose 57.45% to Rs 39.85 crore in the quarter ended September 2026 as against Rs 25.31 crore during the previous quarter ended September 2025. Sales rose 30.38% to Rs 316.09 crore in the quarter ended September 2026 as against Rs 242.43 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	316.09	242.43	30
OPM %	21.40	19.95	-
PBDT	63.26	44.06	44
PBT	52.82	34.04	55
NP	39.85	25.31	57

Powered by Capital Market - Live News